Walder Wyss advises BioVersys AG, Basel, a biotech company focusing on research and development of small molecules which switch off drug resistance against antibiotics, on its…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now